Organogenesis Holdings (ORGO) Assets Average (2016 - 2026)

Organogenesis Holdings' Assets Average history runs 11 years deep, the most recent figure standing at $559.4 million for Q1 2026.

• In Q1 2026, Assets Average rose 15.9% year-over-year to $559.4 million; the TTM figure through Mar 2026 stood at $559.4 million (up 15.9% YoY), while the FY2025 annual figure was $548.3 million, up 14.48% from the prior year.
• Assets Average was $559.4 million for Q1 2026 at Organogenesis Holdings, up from $554.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $559.4 million in Q1 2026 to a low of $439.8 million in Q1 2022.
• Historically, Assets Average has averaged $469.6 million across 5 years, with a median of $456.8 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Assets Average soared 44.33% in 2022, then fell 2.57% in 2024.
• A 5-year view of Assets Average shows it stood at $453.3 million in 2022, then increased by 1.77% to $461.3 million in 2023, then advanced by 2.33% to $472.1 million in 2024, then gained by 17.41% to $554.3 million in 2025, then increased by 0.92% to $559.4 million in 2026.
• The last three Assets Average figures came in at $559.4 million (Q1 2026), $554.3 million (Q4 2025), and $485.5 million (Q3 2025), per Business Quant data.